Bodhi Tree Biotechnology Stock Price, News & Analysis
Company Description
Bodhi Tree Biotechnology (OTC Link: BDTB) is a publicly traded company.
On a trailing twelve-month basis, Bodhi Tree Biotechnology reported revenue of $17K with net income of -$150K and diluted earnings per share of $-0.01. The company operates at a net profit margin of -880.4%.
This page provides a comprehensive overview of BDTB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bodhi Tree Biotechnology (BDTB) stock last traded at $0.2000.
Latest News
SEC Filings
Bodhi Tree Biotechnology has filed 2 recent SEC filings, including 1 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on February 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BDTB SEC filings →
Financial Highlights
Bodhi Tree Biotechnology generated $17K in revenue over the trailing twelve months, operating income reached -$148K (-868.3% operating margin), and net income was -$150K, reflecting a -880.4% net profit margin. Diluted earnings per share stood at $-0.01. The company generated -$150K in operating cash flow.